Less is more in octreotide therapy for esophageal variceal hemorrhage

FHS
October 7, 2024
11:58 pm

Researchers at the Medical University of South Carolina revealed the need to clarify current treatment guidelines for octreotide therapy following an esophageal variceal hemorrhage in a recent study from the American Journal of Medical Sciences.

Ubiquigent collaborates with Imperial College London on DUB probe discovery to facilitate preclinical and clinical target engagement studies

Ubiquigent Limited (Ubiquigent), a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therapeutics for areas of high unmet medical need, today

October 4, 2023

FDA approves Idorsia’s high blood pressure drug for patients who need other options

The FDA on Tuesday approved Idorsia’s new treatment for patients with high blood pressure who aren’t adequately treated by current medications. But the drug comes

March 21, 2024

New glass powder shows promise for stopping bleeding and preventing infections

Can a glass powder that was developed to stop bleeding after gunshot wounds and other body trauma also serve as an antibacterial and help stave

November 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.